Resultados da busca - Isabelle Bedrosian

Refinar Resultados
  1. 1
    Contralateral prophylactic mastectomy: current perspectives

    Contralateral prophylactic mastectomy: current perspectives por Katharine Yao, Mark Sisco, Isabelle Bedrosian

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients

    Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients por Isabelle Bedrosian, Che‐Yuan Hu, G. J. Chang

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

    The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer por Anjana Bhardwaj, Harpreet Singh, Celestine Trinidad, Constance T. Albarracin, Kelly K. Hunt, Isabelle Bedrosian

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes

    Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes por Amy C. Moreno, Yan Lin, Isabelle Bedrosian, Yu Shen, Gildy V. Babiera, Simona F. Shaitelman

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database

    Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database por Natasha M. Rueth, Heather Lin, Isabelle Bedrosian, Simona F. Shaitelman, Naoto T. Ueno, Yu Shen, Gildy V. Babiera

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database

    Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the N... por Samantha M. Buszek, Heather Lin, Isabelle Bedrosian, Nina Tamirisa, Gildy V. Babiera, Yu Shen, Simona F. Shaitelman

    Publicado em 2019
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia

    Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia por Rhiana Menen, Nivetha Ganesan, Therese B. Bevers, Binwu Ying, Robin Coyne, Deanna L. Lane, Constance T. Albarracin, Isabelle Bedrosian

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer

    Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer por Anjana Bhardwaj, Harpreet Singh, Kimal Rajapakshe, Kazunoshin Tachibana, Nivetha Ganesan, Yinghong Pan, Preethi H. Gunaratne, Cristian Coarfa, Isabelle Bedrosian

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast Cancer

    Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast Cancer por Nina Tamirisa, Heather Lin, Yu Shen, Simona F. Shaitelman, Meghan Karuturi, Sharon H. Giordano, Gildy V. Babiera, Isabelle Bedrosian

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer

    Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer por Meeghan A. Lautner, Heather Lin, Yu Shen, Catherine Parker, Henry M. Kuerer, Simona F. Shaitelman, Gildy V. Babiera, Isabelle Bedrosian

    Publicado em 2015
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members

    Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surg... por Abigail S. Caudle, Isabelle Bedrosian, Denái R. Milton, Sarah M. DeSnyder, Henry M. Kuerer, Kelly K. Hunt, Elizabeth A. Mittendorf

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

    HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer por Julie E. Lang, Kailash Mosalpuria, Massimo Cristofanilli, Savitri Krishnamurthy, James M. Reuben, Balraj Singh, Isabelle Bedrosian, Funda Meric‐Bernstam, Anthony Lucci

    Publicado em 2008
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status

    Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status por Abenaa M. Brewster, Isabelle Bedrosian, Patricia A. Parker, Wenli Dong, Susan K. Peterson, Scott B. Cantor, Melissa A. Crosby, Yu Shen

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients

    A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients por Isabelle Bedrosian, Gildy V. Babiera, Elizabeth A. Mittendorf, Henry M. Kuerer, Laura Pantoja, Kelly K. Hunt, Savitri Krishnamurthy, Funda Meric‐Bernstam

    Publicado em 2010
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism

    Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependen... por Shuwen Xu, Gary K. Koski, Mark B. Faries, Isabelle Bedrosian, Rosemarie Mick, Markus Maeurer, Martin A. Cheever, Peter A. Cohen, Brian J. Czerniecki

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population

    Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population por Min Yi, Henry M. Kuerer, Elizabeth A. Mittendorf, Rosa F. Hwang, Abigail S. Caudle, Isabelle Bedrosian, Funda Meric‐Bernstam, Jamie L. Wagner, Kelly K. Hunt

    Publicado em 2012
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    High incidence of germline <i>BRCA</i> mutation in patients with ER low‐positive/PR low‐positive/HER‐2 <i>neu</i> negative tumors

    High incidence of germline <i>BRCA</i> mutation in patients with ER low‐positive/PR low‐positive/HER‐2 <i>neu</i> negative tumors por Rachel Sanford, Juhee Song, Angelica M. Gutierrez‐Barrera, Jessica Profato, Ashley Woodson, Jennifer K. Litton, Isabelle Bedrosian, Constance T. Albarracin, Vicente Valero, Banu K. Arun

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Trends in and Outcomes from Sentinel Lymph Node Biopsy (SLNB) Alone vs. SLNB with Axillary Lymph Node Dissection for Node-Positive Breast Cancer Patients: Experience from the SEER Database

    Trends in and Outcomes from Sentinel Lymph Node Biopsy (SLNB) Alone vs. SLNB with Axillary Lymph Node Dissection for Node-Positive Breast Cancer Patients: Experience from the SEER... por Min Yi, Sharon H. Giordano, Funda Meric‐Bernstam, Elizabeth A. Mittendorf, Henry M. Kuerer, Rosa F. Hwang, Isabelle Bedrosian, Loren L. Rourke, Kelly K. Hunt

    Publicado em 2010
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer

    Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer por Min Yi, Savitri Krishnamurthy, Henry M. Kuerer, Funda Meric‐Bernstam, Isabelle Bedrosian, Merrick I. Ross, Frederick C. Ames, Anthony Lucci, Rosa F. Hwang, Kelly K. Hunt

    Publicado em 2008
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision

    Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision por Min Yi, Funda Meric‐Bernstam, Henry M. Kuerer, Elizabeth A. Mittendorf, Isabelle Bedrosian, Anthony Lucci, Rosa F. Hwang, Jaime R. Crow, Sheng Luo, Kelly K. Hunt

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: